Nascent Biotech, Inc.
Nascent Biotech, Inc. (NBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NBIO · as of Jun 9, 2026
Key Statistics
Explore Nascent Biotech, Inc. Data
nbio stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
nbio competitorsNBIO
BSYI
CHNXF
CWWBF
FCHS
PZOOStock Performance
Full HistoryAbout Nascent Biotech, Inc.
Nascent Biotech, Inc. a clinical-stage biopharmaceutical firm, is committed to creating monoclonal antibody-based treatments for various forms of cancer. A primary focus is Pritumumab, a therapeutic …
what is nascent biotech, inc. · nbio stock overview · nascent biotech, inc. company profile · who is nascent biotech, inc. ceo · nbio OTC · nascent biotech, inc. headquarters · nascent biotech, inc. business segments
About Stock Overview & Key Data
Nascent Biotech, Inc. (NBIO) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 3, 2009. As of the latest trading session, NBIO stock price is $0.00, with a market capitalization of $68,887. The stock has returned +100.00% over the past 12 months and -33.33% year-to-date.
In fiscal year 2024, Nascent Biotech, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nascent Biotech, Inc. (NBIO) stock price is $0.00. The stock is traded on OTC under the ticker symbol NBIO. The 52-week range is $0.00 – $0.13.